Related Experiment Videos
Aspirin and coronary heart disease. Clinical applications
1Clinical Haematology Unit, Westmead Hospital, New South Wales.
Australian Family Physician
|February 1, 1990
Insights
Low-dose aspirin (60-100 mg daily) is beneficial for patients with a history of cardiovascular events. This anti-platelet therapy helps prevent further complications like heart attack and stroke.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Aspirin is a well-established anti-platelet agent.
- Cardiovascular diseases such as unstable angina, myocardial infarction, and stroke represent significant health concerns.
Purpose of the Study:
- To evaluate the benefit of low-dose aspirin in patients with a history of specific cardiovascular events.
- To determine the efficacy of aspirin as an anti-platelet agent in secondary prevention.
Main Methods:
- Administration of low-dose aspirin (60-100 mg daily).
- Patient cohort included individuals with a history of unstable angina, myocardial infarction, transient ischaemic attacks, and stroke.
Main Results:
- Low-dose aspirin demonstrated beneficial effects in the studied patient population.
- The anti-platelet action of aspirin contributes to its therapeutic value in this context.
Conclusions:
- Low-dose aspirin is a valuable therapeutic option for secondary prevention in patients with a history of cardiovascular events.
- Consistent use of low-dose aspirin can help mitigate the risk of recurrent ischaemic events.
Abstract:
Aspirin, which is an effective anti-platelet agent, given in the low dosage of 60 to 100 mg per day appears to be beneficial for patients with a history of unstable angina, myocardial infarction, transient ischaemic attacks and stroke.